{
    "clinical_study": {
        "@rank": "21685", 
        "arm_group": [
            {
                "arm_group_label": "HD 203", 
                "arm_group_type": "Active Comparator", 
                "description": "prefilled syringe"
            }, 
            {
                "arm_group_label": "Enbrel", 
                "arm_group_type": "Experimental", 
                "description": "prefilled syringe"
            }
        ], 
        "brief_summary": {
            "textblock": "The purpose of this study is to compare the safety and pharmacokinetic characteristics of\n      HD203 liquid with those of etanercept (enbrel) prefilled injection after subcutaneous\n      injection"
        }, 
        "brief_title": "Safety and Pharmacokinetic Characteristics of HD203 Liquid in Healthy Male Volunteers", 
        "completion_date": {
            "#text": "December 2013", 
            "@type": "Anticipated"
        }, 
        "condition": "Healthy", 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  20 to 40 years of healthy volunteers\n\n        Exclusion Criteria:\n\n          -  Subject who had been treated with Etanercept before"
            }, 
            "gender": "Male", 
            "healthy_volunteers": "Accepts Healthy Volunteers", 
            "maximum_age": "40 Years", 
            "minimum_age": "20 Years"
        }, 
        "enrollment": {
            "#text": "48", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "July 3, 2013", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01894412", 
            "org_study_id": "EAGLE-I-13"
        }, 
        "intervention": [
            {
                "arm_group_label": [
                    "HD 203", 
                    "Enbrel"
                ], 
                "intervention_name": "Etanercept (Enbrel)", 
                "intervention_type": "Biological"
            }, 
            {
                "arm_group_label": [
                    "HD 203", 
                    "Enbrel"
                ], 
                "intervention_name": "HD203", 
                "intervention_type": "Biological"
            }
        ], 
        "intervention_browse": {
            "mesh_term": [
                "TNFR-Fc fusion protein", 
                "Immunoglobulin G"
            ]
        }, 
        "is_fda_regulated": "Yes", 
        "is_section_801": "Yes", 
        "lastchanged_date": "November 10, 2013", 
        "location": {
            "facility": {
                "address": {
                    "city": "Seoul", 
                    "country": "Korea, Republic of"
                }, 
                "name": "Seoul National University Hospital"
            }
        }, 
        "location_countries": {
            "country": "Korea, Republic of"
        }, 
        "number_of_arms": "2", 
        "official_title": "A Randomized, Double-blind, Single-dosing, Crossover Study to Compare the Safety and Pharmacokinetic Characteristics of HD203 25 mg With Those of Enbrel\u00ae Injection 25 mg After Subcutaneous Injection in Healthy Male Volunteers", 
        "overall_official": {
            "affiliation": "Seoul National University Hospital", 
            "last_name": "Kyung-Sang Yu", 
            "role": "Principal Investigator"
        }, 
        "overall_status": "Active, not recruiting", 
        "oversight_info": {
            "authority": "Korea: Ministry of Food and Drug Safety", 
            "has_dmc": "No"
        }, 
        "phase": "Phase 1", 
        "primary_completion_date": {
            "#text": "December 2013", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": {
            "measure": "Area under the concentration-time curve of the analyte in plasma over the time interval from 0 extrapolated to infinity", 
            "safety_issue": "No", 
            "time_frame": "up to 56 days"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01894412"
        }, 
        "responsible_party": {
            "responsible_party_type": "Sponsor"
        }, 
        "source": "Hanwha Chemical", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "Hanwha Chemical", 
                "agency_class": "Industry"
            }
        }, 
        "start_date": "July 2013", 
        "study_design": "Allocation: Randomized, Intervention Model: Crossover Assignment, Masking: Double Blind (Subject, Caregiver, Investigator, Outcomes Assessor), Primary Purpose: Treatment", 
        "study_type": "Interventional", 
        "verification_date": "November 2013"
    }
}